First Trust/Confluence Small Cap Value Fund Class A
FOVAX
NASDAQ
Weiss Ratings | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C+ | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Company Info | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | First Trust | |||
Manager/Tenure (Years) | Mark A. Keller (14), Daniel T. Winter (14), Thomas Dugan (9) | |||
Website | http://www.ftportfolios.com/ | |||
Fund Information | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | First Trust/Confluence Small Cap Value Fund Class A | |||
Category | Small Blend | |||
Sub-Category | US Equity Small Cap | |||
Prospectus Objective | Small Company | |||
Inception Date | Feb 24, 2011 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,500.00 | |||
Minimum Subsequent Investment | 50.00 | |||
Front End Fee | 0.06 | |||
Back End Fee | -- | |||
Dividends and Shares | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.00% | |||
Dividend | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.10% | |||
Asset Allocation | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | -0.36% | |||
Stock | 100.35% | |||
U.S. Stock | 96.97% | |||
Non-U.S. Stock | 3.38% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.76% | |||
30-Day Total Return | 3.30% | |||
60-Day Total Return | 3.30% | |||
90-Day Total Return | -0.70% | |||
Year to Date Total Return | -4.76% | |||
1-Year Total Return | -4.86% | |||
2-Year Total Return | -0.75% | |||
3-Year Total Return | 6.46% | |||
5-Year Total Return | 21.82% | |||
Price | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | -- | |||
1-Month Low NAV | $25.24 | |||
1-Month High NAV | $26.22 | |||
52-Week Low NAV | $23.25 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $32.02 | |||
52-Week High Price (Date) | Jul 30, 2024 | |||
Beta / Standard Deviation | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.04 | |||
Standard Deviation | 21.02 | |||
Balance Sheet | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 15.32M | |||
Operating Ratios | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.60% | |||
Turnover Ratio | 17.00% | |||
Performance | FOVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 13.69% | |||
Last Bear Market Total Return | -12.32% | |||